Clinical Trials Logo

Prostate Carcinoma clinical trials

View clinical trials related to Prostate Carcinoma.

Filter by:

NCT ID: NCT03697148 Recruiting - Prostate Carcinoma Clinical Trials

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Start date: February 11, 2019
Phase: N/A
Study type: Interventional

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

NCT ID: NCT03661437 Active, not recruiting - Prostate Carcinoma Clinical Trials

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

Start date: September 24, 2018
Phase: Early Phase 1
Study type: Interventional

This pilot trial studies how well systemic light exposure works in preventing frailty in older patients with prostate cancer on hormonal therapy. Hormone therapy causes many symptoms of frailty in older men including fatigue, slower time to walk a specified distance, reduced activity levels, loss of lean muscle, and muscle weakness. It is not yet known if systemic light exposure may reduce frailty in older prostate cancer patients.

NCT ID: NCT03630354 Completed - Breast Carcinoma Clinical Trials

EXERCISING TOGETHER for Couples Coping With Cancer

Start date: January 18, 2019
Phase: N/A
Study type: Interventional

The Exercising Together trial is a single-blind, parallel group, randomized controlled trial comparing 3 arms: Arm 1 (experimental): Exercising Together where couples perform partnered exercise in a supervised, group setting versus two comparator conditions where survivors and partners perform exercise routines separately in either a supervised group setting (Arm 2) or unsupervised at home (Arm 3). All three arms will train for a 6-month period and then be followed 6 months later. Data will be collected at baseline, 3, 6 and 12 months.

NCT ID: NCT03580499 Active, not recruiting - Hot Flashes Clinical Trials

Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy

Start date: September 13, 2018
Phase: N/A
Study type: Interventional

This pilot phase II trial studies how well vitamin B6 works in reducing hot flashes in participants with prostate cancer undergoing antiandrogen therapy. A nutritional supplement such as vitamin B6 may help improve hot flashes caused by antiandrogen therapy in participants with prostate cancer.

NCT ID: NCT03563352 Withdrawn - Cholangiocarcinoma Clinical Trials

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Start date: August 30, 2018
Phase:
Study type: Observational

This trial studies nutritional preferences and product accessibility in oral nutritional supplements in participants with breast, colorectal, upper gastrointestinal, or prostate cancer. Learning what participants like and dislike about their current or past used nutritional supplements may help doctor know how to improve them.

NCT ID: NCT03485794 Recruiting - Prostate Carcinoma Clinical Trials

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Start date: November 14, 2017
Phase:
Study type: Observational

This pilot research trial utilizes the collection of blood in studying metabolites in patients with prostate cancer. Metabolites are the small molecule products of cellular metabolism that are produced naturally in all living cells. Collecting blood in order to study metabolites may help doctors monitor and treat prostate cancer more effectively.

NCT ID: NCT03418025 Completed - Prostate Carcinoma Clinical Trials

Exercising Together During Radiation Treatment

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well the Exercising Together program works in helping couples cope with radiation treatment for prostate cancer. Treatments for cancer can cause side effects for the patient, such as fatigue, add stress for the spousal caregiver, and put strain on the marital relationship. The Exercising Together program is designed to promote teamwork and emotional intimacy during exercise, which itself can help manage fatigue and stress for the patient and spouse, and may facilitate communication between partners about day-to-day energy, abilities, and motivation.

NCT ID: NCT03408561 Withdrawn - Lymphoma Clinical Trials

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

Start date: November 8, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well social media listening works in improving clinical trial recruitment in patients with cancer. Social media listening and recruitment on Twitter may enhance enrollment for cancer-related clinical trials.

NCT ID: NCT03406013 Completed - Prostate Carcinoma Clinical Trials

Internet-Based Exercise and Diet Support in Prostate Cancer Survivors

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well the True NTH Community of Wellness internet-based exercise and diet support works in improving diet and exercise habits in prostate cancer survivors. Internet-based exercise and diet support may help better control treatment-related side effects and symptoms, better overall quality of life, and lower risk factors associated with cancer progression.

NCT ID: NCT03326440 Completed - Prostate Carcinoma Clinical Trials

Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer

VERT
Start date: October 8, 2015
Phase: N/A
Study type: Interventional

Purpose of the study 1. To assess whether offering visual information to patients with prostate cancer prior to receiving RT increases the participant's compliance. 2. To assess whether increased compliance translates into reduced side effects from RT (assessed with a quality of life questionnaire). Type of study. This is a randomised control trial which will include 170 patients with the histological diagnosis of prostate cancer in the study arm and 170 patients with the histological diagnosis of prostate cancer in the control/standard arm.